Global Electronic Data Capture Edc Systems Market
Market Size in USD Billion
CAGR :
% 
USD
1.70 Billion
USD
3.81 Billion
2023
2031
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 1.70 Billion |
 Market Size (Forecast Year) |
USD 3.81 Billion |
 CAGR |
% |
| Major Markets Players |
Global Electronic Data Capture (EDC) Systems Market, By Delivery Mode (Web-hosted, Cloud-based, Licensed Enterprise), Clinical Trial Phase (Phase I, Phase II, Phase III and Phase IV), End-User (Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Medical Device Companies and Hospitals) – Industry Trends and Forecast to 2031.
Electronic Data Capture (EDC) Systems Market Analysis and Size
The electronic data capture (EDC) systems market has witnessed significant growth over the recent years, driven by the increasing demand for efficient data collection, management, and analysis across the clinical research sector. The growing number of clinical trials in pharmaceutical and biotechnology sectors is also contributing to the EDC systems market growth. For instance, according to World Health Organization International Clinical Trials Registry Platform (ICTRP), the clinical trials globally increased from 57,039 in 2019 to 65,409 in 2021. Thus, EDC becomes a crucial tool or solution for efficiently managing vast amounts of clinical trial data, leading to their widespread adoption, thereby fostering the market growth.
Data Bridge Market Research analyses that the global electronic data capture (EDC) systems market, which was USD 1.7 billion in 2023, is expected to reach USD 3.81 billion by 2031, and is expected to undergo a CAGR of 10.6% during the forecast period 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable to 2016-2021) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Delivery Mode (Web-hosted, Cloud-based, Licensed Enterprise), Clinical Trial Phase (Phase I, Phase II, Phase III and Phase IV), End-User (Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Medical Device Companies and Hospitals) |
|
Countries Covered |
U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific, South Africa, Rest of Middle East and Africa, Brazil, and Rest of South America |
|
Market Players Covered |
OpenClinica, LLC (U.S.), Medidata Solution, Inc. (U.S.), Datatrak International, Inc. (U.S.), Eclinical solutions (U.S.), Acceliant (U.S.), Oracle (U.S.), Omni Comm Systems, Inc. (U.S.), DSG, Inc. (U.S.), Veeva Systems (U.S.), MedNet (U.S.) among others |
|
Market Opportunities |
|
Market Definition
Electronic data capture systems (EDC) are designed for the collection of clinical trial data in an electronic format. The majority of data collected in an EDC system is primarily related to managing electronic case report form (eCRF) data. The common function of EDC includes a graphical-user interface component for data entry and unique and secure user permission within the system. In addition, these systems are used to replace traditional paper-based data collection methods, allowing organizations to streamline data-related processes and improve data accuracy and efficiency.
Global Electronic Data Capture (EDC) Systems Market Dynamics
Drivers
- Increasing Clinical Trials and Research Activities
The global pharmaceutical and biotechnology industries are experiencing a surge in clinical trials and research activities, driven by factors such as the growing prevalence of chronic diseases, the need for innovative treatments, and regulatory requirements for drug development and approval. EDC systems play a crucial role in streamlining data collection, management, and analysis in clinical trials, offering efficiency, accuracy, and real-time access to data. The rising number of clinical trials worldwide fuels the demand for EDC systems, driving market growth.
- Advancements in Healthcare Technology and IT infrastructure
Technological advancements in healthcare IT infrastructure, including cloud computing, mobile technologies, and data analytics, have transformed the landscape of clinical data management. EDC systems leverage these advancements to offer scalable, secure, and user-friendly platforms for capturing, storing, and analyzing clinical trial data. The adoption of EDC systems is driven by the need for interoperability, data integration, and real-time access to clinical data across geographically dispersed sites, facilitating efficient collaboration among stakeholders and accelerating clinical trial timelines.
- Growing Investment for Healthcare Facilities
Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.
Opportunities
- Expansion in Emerging Markets
Emerging economies, particularly in Asia-Pacific, Latin America, and the Middle East, are witnessing rapid growth in clinical research and pharmaceutical industries. The increasing prevalence of chronic diseases, rising healthcare expenditure, and improvements in regulatory frameworks present significant opportunities for the adoption of EDC systems in these regions. EDC vendors can capitalize on the growing demand for clinical trial solutions by expanding their presence in emerging markets, customizing offerings to meet local regulatory requirements, and addressing the unique needs of diverse healthcare ecosystems.
- Integration with Real-World Data (RWD) Sources
The integration of EDC systems with real-world data (RWD) sources such as electronic health records (EHRs), wearable devices, and patient-generated health data (PGHD) presents opportunities to enhance the value proposition of EDC platforms. EDC systems can provide comprehensive insights into patient health outcomes, treatment efficacy, and safety profiles, enabling researchers to conduct more robust real-world evidence (RWE) studies and post-marketing surveillance. EDC vendors can seize opportunities to develop interoperable solutions that bridge the gap between clinical trials and real-world practice, offering holistic data management solutions to sponsors, regulators, and healthcare stakeholders.
Restraints
- High Implementation and Maintenance Costs
The initial investment required for implementing EDC systems, including software licensing, hardware infrastructure, and staff training, can be substantial. Additionally, ongoing maintenance and support costs further contribute to the total cost of ownership. For smaller organizations, especially those in resource-constrained settings or with limited budgets, the high upfront and recurring costs associated with EDC systems may act as a barrier to adoption, restraining market growth.
- Data Security and Privacy Concerns
EDC systems involve the collection, storage, and transmission of sensitive clinical trial data, including patient health information and study outcomes. Ensuring data security, protecting patient privacy, and complying with regulatory requirements such as the Health Insurance Portability and Accountability Act (HIPAA) in the U.S and the General Data Protection Regulation (GDPR) in Europe are critical considerations for EDC vendors and healthcare organizations. Concerns about data breaches, cybersecurity threats, and regulatory non-compliance may deter adoption or slow the implementation of EDC systems, particularly among organizations with stringent data security requirements.
Challenges
- Complexity of System Integration and Interoperability
EDC systems need to integrate seamlessly with existing electronic health record (EHR) systems, laboratory information management systems (LIMS), and other clinical trial management platforms to enable data exchange and interoperability. However, the complexity of system integration, compatibility issues, and interoperability challenges between disparate systems can hinder the implementation process. Healthcare organizations may face difficulties in achieving seamless integration, leading to delays, increased costs, and operational disruptions.
- Resistance to Change and Staff Training
The implementation of EDC systems often requires changes to existing workflows, roles, and processes within healthcare organizations and clinical research teams. Resistance to change among stakeholders, including investigators, research coordinators, and study personnel, can pose a significant barrier to adoption. Additionally, inadequate training and support for end-users may result in low user acceptance, reduced system utilization, and inefficiencies in data capture and management.
This global electronic data capture (EDC) systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global electronic data capture (EDC) systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In February 2022, Clinixir Company Limited, a leading Thailand-based CRO, opted for Oracle’s pharmacovigilance and clinical research solutions as its eClinical platform. This included the Oracle Clinical One EDC as part of the solutions implemented. This strategy helped the company to boost their revenue growth
- In March 2020, Elsevier, a key information analytics provider, launched Veridata EDC to capture patient data for clinical research. The solution was made available for free to researchers working to develop COVID-19 vaccines and other therapies. This helped company to expand their product offerings and customer base
Global Electronic Data Capture (EDC) Systems Market Scope
The global electronic data capture (EDC) systems market is segmented on the basis of delivery mode, clinical trial phase and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Delivery Mode
- Cloud-Based (SAAS) Solutions
- Web-Hosted (on-demand) Solutions
- Licensed Enterprise (on-premise) Solutions
Clinical Trial Phase
- Phase I
- Phase II
- Phase III
- Phase IV
End-User
- Contract Research Organizations (CROs)
- Pharmaceutical and Biotechnology Companies
- Medical Device Companies
- Hospitals
- Other End-Users
Global Electronic Data Capture (EDC) Systems Market Regional Analysis/Insights
The global electronic data capture (EDC) systems market is analysed and market size insights and trends are provided by country, delivery mode, clinical trial phase and end-user as referenced above.
The countries covered in the global electronic data capture (EDC) systems market report are U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Indonesia, Philippines, rest of Asia-Pacific (APAC), Brazil, rest of South America in South America, South Africa, and rest of Middle East and Africa in Middle East and Africa (MEA).
North America electronic data capture (EDC) systems market is dominating due to the strong foothold of major pharmaceutical and biotechnology companies, medical device companies and research and academic institutions boost the market growth. In addition, availability of sophisticated infrastructure further drives the regional growth.
Asia-Pacific is projected to observe significant amount of growth in the electronic data capture (EDC) systems market due to the rapid necessity for telemedicine and healthcare support. Moreover, the modernization and development in telecommunication is further anticipated to propel the growth of the electronic data capture (EDC) systems market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure GROWTH INSTALLED BASE and New Technology Penetration
The global electronic data capture (EDC) systems market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global electronic data capture (EDC) systems market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global electronic data capture (EDC) systems market . The data is available for historic period 2016-2021.
Competitive Landscape and Global Electronic Data Capture (EDC) Systems Market Share Analysis
The global electronic data capture (EDC) systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global electronic data capture (EDC) systems market .
Some of the major players operating in the global electronic data capture (EDC) systems market are:
- OpenClinica, LLC (U.S.)
- Medidata Solution, Inc. (U.S.)
- Datatrak International, Inc. (U.S.)
- Eclinical solutions (U.S.)
- Acceliant (U.S.)
- Oracle - (U.S.)
- Omni Comm Systems, Inc. (U.S.)
- DSG, Inc. (U.S.)
- Veeva Systems -(U.S.)
- MedNet (U.S.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1. INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL ELECTRONIC DATA CAPTURE (EDC) SYSTEMS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2. MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL ELECTRONIC DATA CAPTURE (EDC) SYSTEMS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 TOP TO BOTTOM ANALYSIS
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 VENDOR SHARE ANALYSIS
2.2.10 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.11 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL ELECTRONIC DATA CAPTURE (EDC) SYSTEMS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3. MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
5.3 IN-DEPTH ANALYSIS OF OPERATIONAL TECNIQUES, BY COUNTRY
6. INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7. COST ANALYSIS BREAKDOWN
8. TECHNONLOGY ROADMAP
9. INNOVATION TRACKER AND STRATEGIC ANALYSIS
9.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
9.1.1 JOINT VENTURES
9.1.2 MERGERS AND ACQUISITIONS
9.1.3 LICENSING AND PARTNERSHIP
9.1.4 TECHNOLOGY COLLABORATIONS
9.1.5 STRATEGIC DIVESTMENTS
9.2 NUMBER OF PRODUCTS IN DEVELOPMENT
9.3 STAGE OF DEVELOPMENT
9.4 TIMELINES AND MILESTONES
9.5 INNOVATION STRATEGIES AND METHODOLOGIES
9.6 RISK ASSESSMENT AND MITIGATION
9.7 FUTURE OUTLOOK
10. REGULATORY COMPLIANCE
10.1 REGULATORY AUTHORITIES
10.2 REGULATORY CLASSIFICATIONS
10.3 REGULATORY SUBMISSIONS
10.4 INTERNATIONAL HARMONIZATION
10.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
10.6 REGULATORY CHALLENGES AND STRATEGIES
11. VALUE CHAIN ANALYSIS
12. HEALTHCARE ECONOMY
12.1 HEALTHCARE EXPENDITURE
12.2 CAPITAL EXPENDITURE
12.3 CAPEX TRENDS
12.4 CAPEX ALLOCATION
12.5 FUNDING SOURCES
12.6 INDUSTRY BENCHMARKS
12.7 GDP RATION IN OVERALL GDP
12.8 HEALTHCARE SYSTEM STRUCTURE
12.9 GOVERNMENT POLICIES
12.10 ECONOMIC DEVELOPMENT
13. GLOBAL ELECTRONIC DATA CAPTURE (EDC) SYSTEMS MARKET, BY COMPONENT
13.1 OVERVIEW
13.2 SOFTWARE
13.2.1 BY FUNCTION
13.2.1.1. TRIAL DESIGN
13.2.1.2. DATA VERIFICATION
13.2.1.3. DATA ANALYSIS
13.2.1.4. DATA COLLECTION
13.2.1.5. OTHERS
13.2.2 BY MODE
13.2.2.1. INTEGRATED
13.2.2.2. STANDALONE
13.2.2.3. BY OPERATING SYSTEM
13.2.2.4. WINDOWS
13.2.2.5. IOS
13.2.2.6. OTHERS
13.3 SERVICES
13.3.1 MANAGED
13.3.2 PROFESSIONAL
14. GLOBAL ELECTRONIC DATA CAPTURE (EDC) SYSTEMS MARKET, BY DEPLOYMENT MODEL
14.1 OVERVIEW
14.2 CLOUD-BASED MODEL
14.3 WEB-HOSTED
14.4 OTHERS
15. GLOBAL ELECTRONIC DATA CAPTURE (EDC) SYSTEMS MARKET, BY PURCHASE MODE
15.1 OVERVIEW
15.2 SUBSCRIPTION BASED
15.3 IN-LICENSING
15.4 OTHERS
16. GLOBAL ELECTRONIC DATA CAPTURE (EDC) SYSTEMS MARKET, BY ORGANIZATION TYPE
16.1 OVERVIEW
16.2 GROUP PURCHASE
16.3 INDIVIDUAL PURCHASE
17. GLOBAL ELECTRONIC DATA CAPTURE (EDC) SYSTEMS MARKET, BY CLINICAL TRIAL PHASE
17.1 OVERVIEW
17.2 PHASE I
17.2.1 SOFTWARE
17.2.2 SERVICES
17.3 PHASE II
17.3.1 SOFTWARE
17.3.2 SERVICES
17.4 PHASE III
17.4.1 SOFTWARE
17.4.2 SERVICES
17.5 PHASE IV
17.5.1 SOFTWARE
17.5.2 SERVICES
18. GLOBAL ELECTRONIC DATA CAPTURE (EDC) SYSTEMS MARKET, BY END USER
18.1 OVERVIEW
18.2 MEDICAL DEVICE COMPANIES
18.2.1 SMALL
18.2.2 MEDIUM
18.2.3 LARGE
18.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
18.3.1 SMALL
18.3.2 MEDIUM
18.3.3 LARGE
18.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
18.4.1 SMALL
18.4.2 MEDIUM
18.4.3 LARGE
18.5 HEALTCHARE FACILITIES
18.5.1 SMALL
18.5.2 MEDIUM
18.5.3 LARGE
18.6 OTHERS
19. GLOBAL ELECTRONIC DATA CAPTURE (EDC) SYSTEMS MARKET, BY REGION
19.1 GLOBAL ELECTRONIC DATA CAPTURE (EDC) SYSTEMS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
19.2 NORTH AMERICA
19.2.1 U.S.
19.2.2 CANADA
19.2.3 MEXICO
19.3 EUROPE
19.3.1 GERMANY
19.3.2 FRANCE
19.3.3 U.K.
19.3.4 FINLAND
19.3.5 DENMARK
19.3.6 NORWAY
19.3.7 POLAND
19.3.8 ITALY
19.3.9 SPAIN
19.3.10 RUSSIA
19.3.11 TURKEY
19.3.12 BELGIUM
19.3.13 NETHERLANDS
19.3.14 SWITZERLAND
19.3.15 SWEDEN
19.3.16 REST OF EUROPE
19.4 ASIA-PACIFIC
19.4.1 JAPAN
19.4.2 CHINA
19.4.3 SOUTH KOREA
19.4.4 INDIA
19.4.5 SINGAPORE
19.4.6 THAILAND
19.4.7 INDONESIA
19.4.8 MALAYSIA
19.4.9 PHILIPPINES
19.4.10 AUSTRALIA
19.4.11 NEW ZEALAND
19.4.12 VIETNAM
19.4.13 TAIWAN
19.4.14 REST OF ASIA-PACIFIC
19.5 SOUTH AMERICA
19.5.1 BRZIL
19.5.2 ARGENTINA
19.5.3 REST OF SOUTH AMERICA
19.6 MIDDLE EAST AND AFRICA
19.6.1 SOUTH AFRICA
19.6.2 SAUDI ARABIA
19.6.3 UAE
19.6.4 EGYPT
19.6.5 KUWAIT
19.6.6 OMAN
19.6.7 ISRAEL
19.6.8 BAHRAIN
19.6.9 REST OF MIDDLE EAST AND AFRICA
19.7 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
20. GLOBAL ELECTRONIC DATA CAPTURE (EDC) SYSTEMS MARKET, COMPANY LANDSCAPE
20.1 COMPANY SHARE ANALYSIS: GLOBAL
20.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
20.3 COMPANY SHARE ANALYSIS: EUROPE
20.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
20.5 MERGERS & ACQUISITIONS
20.6 EXPANSIONS
20.7 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
21. GLOBAL ELECTRONIC DATA CAPTURE (EDC) SYSTEMS MARKET, SWOT AND DBMR ANALYSIS
22. GLOBAL ELECTRONIC DATA CAPTURE (EDC) SYSTEMS MARKET, COMPANY PROFILE
22.1 OPENCLINICA, LLC
22.1.1 COMPANY OVERVIEW
22.1.2 GEOGRAPHIC PRESENCE
22.1.3 PRODUCT PORTFOLIO
22.1.4 RECENT DEVELOPMENTS
22.2 MEDIDATA (DASSAULT SYSTÈMES)
22.2.1 COMPANY OVERVIEW
22.2.2 GEOGRAPHIC PRESENCE
22.2.3 PRODUCT PORTFOLIO
22.2.4 RECENT DEVELOPMENTS
22.3 FOUNTAYN
22.3.1 COMPANY OVERVIEW
22.3.2 GEOGRAPHIC PRESENCE
22.3.3 PRODUCT PORTFOLIO
22.3.4 RECENT DEVELOPMENTS
22.4 MEDNET
22.4.1 COMPANY OVERVIEW
22.4.2 GEOGRAPHIC PRESENCE
22.4.3 PRODUCT PORTFOLIO
22.4.4 RECENT DEVELOPMENTS
22.5 VEEVA SYSTEMS
22.5.1 COMPANY OVERVIEW
22.5.2 GEOGRAPHIC PRESENCE
22.5.3 PRODUCT PORTFOLIO
22.5.4 RECENT DEVELOPMENTS
22.6 DSG, INC.
22.6.1 COMPANY OVERVIEW
22.6.2 GEOGRAPHIC PRESENCE
22.6.3 PRODUCT PORTFOLIO
22.6.4 RECENT DEVELOPMENTS
22.7 ORACLE
22.7.1 COMPANY OVERVIEW
22.7.2 GEOGRAPHIC PRESENCE
22.7.3 PRODUCT PORTFOLIO
22.7.4 RECENT DEVELOPMENTS
22.8 ACCELIANT
22.8.1 COMPANY OVERVIEW
22.8.2 GEOGRAPHIC PRESENCE
22.8.3 PRODUCT PORTFOLIO
22.8.4 RECENT DEVELOPMENTS
22.9 ECLINICAL SOLUTIONS
22.9.1 COMPANY OVERVIEW
22.9.2 GEOGRAPHIC PRESENCE
22.9.3 PRODUCT PORTFOLIO
22.9.4 RECENT DEVELOPMENTS
22.10 CASTOR
22.10.1 COMPANY OVERVIEW
22.10.2 GEOGRAPHIC PRESENCE
22.10.3 PRODUCT PORTFOLIO
22.10.4 RECENT DEVELOPMENTS
22.11 CALYX
22.11.1 COMPANY OVERVIEW
22.11.2 GEOGRAPHIC PRESENCE
22.11.3 PRODUCT PORTFOLIO
22.11.4 RECENT DEVELOPMENTS
22.12 SITERO
22.12.1 COMPANY OVERVIEW
22.12.2 GEOGRAPHIC PRESENCE
22.12.3 PRODUCT PORTFOLIO
22.12.4 RECENT DEVELOPMENTS
22.13 IQVIA INC
22.13.1 COMPANY OVERVIEW
22.13.2 GEOGRAPHIC PRESENCE
22.13.3 PRODUCT PORTFOLIO
22.13.4 RECENT DEVELOPMENTS
22.14 VERISTAT, LLC.
22.14.1 COMPANY OVERVIEW
22.14.2 GEOGRAPHIC PRESENCE
22.14.3 PRODUCT PORTFOLIO
22.14.4 RECENT DEVELOPMENTS
22.15 GLORANT, LLC USA
22.15.1 COMPANY OVERVIEW
22.15.2 GEOGRAPHIC PRESENCE
22.15.3 PRODUCT PORTFOLIO
22.15.4 RECENT DEVELOPMENTS
22.16 RESEARCH MANAGER
22.16.1 COMPANY OVERVIEW
22.16.2 GEOGRAPHIC PRESENCE
22.16.3 PRODUCT PORTFOLIO
22.16.4 RECENT DEVELOPMENTS
22.17 СLINСAPTURE
22.17.1 COMPANY OVERVIEW
22.17.2 GEOGRAPHIC PRESENCE
22.17.3 PRODUCT PORTFOLIO
22.17.4 RECENT DEVELOPMENTS
22.18 MEDRIO
22.18.1 COMPANY OVERVIEW
22.18.2 GEOGRAPHIC PRESENCE
22.18.3 PRODUCT PORTFOLIO
22.18.4 RECENT DEVELOPMENTS
22.19 VIEDOC TECHNOLOGIES
22.19.1 COMPANY OVERVIEW
22.19.2 GEOGRAPHIC PRESENCE
22.19.3 PRODUCT PORTFOLIO
22.19.4 RECENT DEVELOPMENTS
22.20 BSI BUSINESS SYSTEMS INTEGRATION AG
22.20.1 COMPANY OVERVIEW
22.20.2 GEOGRAPHIC PRESENCE
22.20.3 PRODUCT PORTFOLIO
22.20.4 RECENT DEVELOPMENTS
22.21 CLINION
22.21.1 COMPANY OVERVIEW
22.21.2 GEOGRAPHIC PRESENCE
22.21.3 PRODUCT PORTFOLIO
22.21.4 RECENT DEVELOPMENTS
22.22 INDUCTIVE QUOTIENT
22.22.1 COMPANY OVERVIEW
22.22.2 GEOGRAPHIC PRESENCE
22.22.3 PRODUCT PORTFOLIO
22.22.4 RECENT DEVELOPMENTS
22.23 VIAL
22.23.1 COMPANY OVERVIEW
22.23.2 GEOGRAPHIC PRESENCE
22.23.3 PRODUCT PORTFOLIO
22.23.4 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
23. RELATED REPORTS
24. QUESTIONNAIRE
25. ABOUT DATA BRIDGE MARKET RESEARCH
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
